Armed Forces Institute for Regenerative Medicine to Develop Therapies for
Critically Injured Service Members
CLEVELAND, April 17 /PRNewswire/ -- Cleveland Clinic and Rutgers University are leading one of two civilian research consortia to develop innovative medical therapies for the treatment of wounded service members. Cleveland Clinic will receive more than $10 million from a total of $42.5 million awarded over 5 years to create a new institute called the Armed Forces Institute of Regenerative Medicine (AFIRM).
Cleveland Clinic Orthopedic Surgeon, George Muschler, M.D., is AFIRM's Co-Director, in collaboration with AFIRM Director Joachim Kohn, Ph.D., of Rutgers University. Together Drs. Muschler and Kohn will lead a collaborative network of leading clinician scientists drawn from 15 premier institutions and more than 20 commercial partners nationwide.
"The AFIRM team is deeply committed to offering new recovery options for the brave men and women who have served our country," Dr. Muschler said. "Our collaborative mission is to translate opportunities that are now available in regenerative biology as quickly as possible into practical tools that can be used on the front lines or here at home."
The mission of AFIRM is to accelerate the development of new technologies in the field of regenerative medicine and tissue engineering to effectively serve the needs of injured service members. The research and development of new therapies will focus on the regeneration of bone, muscle, tendon, nerve and blood vessels, as well as new methods for transplantation of limb and facial tissue and the treatment of burns.
Cleveland Clinic President and CEO Delos "Toby" Cosgrove has experienced the devastation of war firsthand and commends the AFIRM project.
"Early in my career, I served as an Air Force surgeon in Vietnam where
I saw military casualties firsthand and witnessed the impact of combat
injuries on the fin
|SOURCE Cleveland Clinic|
Copyright©2008 PR Newswire.
All rights reserved